P. Romine

Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer

H. Vesselle, K. Eaton, R. Martins, 2021, Cureus.

Improving the efficacy of immunotherapy in small cell lung cancer: Leveraging recent scientific discoveries and tumor-specific antigens.

Joseph B Hiatt, J. Hiatt, Daniel Y. Wu, 2022, Seminars in oncology.

18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study

Darrin W. Byrd, Paul Kinahan, D. Mankoff, 2021, Breast cancer research : BCR.

Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database

K. Eaton, R. Martins, Li Li, 2022, JCO oncology practice.

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

D. Wood, H. Vesselle, J. Bauman, 2019, BMC Cancer.

Quality in the Age of Precision Medicine: The Clinician Perspective.

S. Gray, P. Romine, Sophie K Harkins, 2016, Journal of oncology practice.

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility

M. Thornquist, M. Barnett, G. Goodman, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

An Assessment of Primary Care and Pulmonary Provider Perspectives on Lung Cancer Screening

J. Elmore, C. Slatore, Erin K Kross, 2018, Annals of the American Thoracic Society.